"Father of Tamoxifen" to Join MD Anderson
The University of Texas MD Anderson Cancer Center is pleased to announce
that one of the world's preeminent experts in breast cancer research
and treatment, V. Craig Jordan, Ph.D., will join the institution's
efforts to end cancer. Jordan is considered the "Father of Tamoxifen," the groundbreaking therapeutic drug that has saved countless lives.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Middle East Health | Tamoxifen | Texas University